These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5571033)

  • 21. Topical corticosteroids--an experimental evaluation of the vasoconstrictor test as an index of anti-inflammatory activity.
    Reid J; Brookes DB
    Br J Dermatol; 1968 May; 80(5):328-36. PubMed ID: 4873078
    [No Abstract]   [Full Text] [Related]  

  • 22. Plethysmographic recordings of skin pulses. IV. The vasoconstrictive effect of steroids in normal and stripped skin.
    Thune P
    Acta Derm Venereol; 1971; 51(4):261-7. PubMed ID: 4105772
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dermatologic clinical study of betamethasone 17-valerate applied locally].
    Hutsebaut A
    Arch Belg Dermatol Syphiligr; 1967; 23(2):231-62. PubMed ID: 5621251
    [No Abstract]   [Full Text] [Related]  

  • 24. Bioavailability and activity of betamethasone 17-benzoate in gel and cream formulations: comparison with proprietary topical corticosteroid preparations in the vasoconstrictor assay.
    Woodford R; Barry BW
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):338-45. PubMed ID: 4208350
    [No Abstract]   [Full Text] [Related]  

  • 25. A double-blind comparison of fluocinonide and betamethasone valerate ointments.
    McCuistion CH; Schoch EP; Warthan TL
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):44-7. PubMed ID: 4632505
    [No Abstract]   [Full Text] [Related]  

  • 26. The croton oil inflammation suppression assay as a measure of topical corticosteroid potency.
    Ortega E; Rodriguez C; Burdick KH; Place VA; Gonzales L
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):95-7. PubMed ID: 5291641
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative study of the vasoconstrictive activity of preparations containing topical corticosteroids].
    Henschel V; Jaminet F
    J Pharm Belg; 1974; 29(1):3-15. PubMed ID: 4831715
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro penetration through the skin layers of topically applied glucocorticoids.
    Carrer V; Alonso C; Oliver MA; Coderch L
    Drug Test Anal; 2018 Oct; 10(10):1528-1535. PubMed ID: 29788546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Objective determination of the bioavailability of dermocorticoids--influence of the formulation.
    Poelman MC; Leveque JL; Le Gall F
    Br J Dermatol; 1984 Jul; 111 Suppl 27():158-62. PubMed ID: 6743548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of betamethasone 17-benzoate in lipophylic vehicles by reversed-phase high-performance liquid chromatography.
    Maron N; Cristi EA; Ramos AA
    J Pharm Sci; 1988 Jul; 77(7):638-9. PubMed ID: 3171954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical experimentation of a new preparation: "betamethasone-17-valerate" for topical use].
    Piana T
    Minerva Dermatol; 1965 Aug; 40(8):330-4. PubMed ID: 5322468
    [No Abstract]   [Full Text] [Related]  

  • 32. [A new type of topical corticoid. Principle and experimental activity control].
    Escande JP
    Nouv Presse Med; 1972 Jan; 1(3):181-2. PubMed ID: 5061528
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperkeratosis lenticularis perstans (Flegel): report of a case in which the application of betamethasone-17-valerate cream caused complete clearing of the lesions.
    Donald GF; Hunter GA
    Australas J Dermatol; 1967 Jun; 9(1):31-6. PubMed ID: 5590674
    [No Abstract]   [Full Text] [Related]  

  • 34. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
    Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
    Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [THE RHEOLOGICAL CHARACTERISTICS OF OINTMENTS].
    SCHULTE KE
    Farmaco Prat; 1963 Oct; 18():509-29. PubMed ID: 14117133
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 (fingolimod) in combination with betamethasone ointment in NC/Nga mice].
    Tsuji T; Yoshida Y; Fujita T; Kohno T
    Arerugi; 2012 Jul; 61(7):948-58. PubMed ID: 23007332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The lateral spread of clobetasol 17-propionate in the stratum corneum in vivo.
    Ashworth J; Watson WS; Finlay AY
    Br J Dermatol; 1988 Sep; 119(3):351-8. PubMed ID: 3179208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [THE WATER NUMBER OF A HYDROPHILOUS EXCIPIENT FOR UNGUENTS].
    FUMANERI AE
    Boll Chim Farm; 1964 Sep; 103():681-5. PubMed ID: 14227292
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of 14 days of head-down tilt bed rest on cutaneous vasoconstrictor responses in humans.
    Wilson TE; Shibasaki M; Cui J; Levine BD; Crandall CG
    J Appl Physiol (1985); 2003 Jun; 94(6):2113-8. PubMed ID: 12524372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced vasoconstrictor potency of the fixed combination calcipotriol plus betamethasone dipropionate in an innovative aerosol foam formulation vs. other corticosteroid psoriasis treatments.
    Queille-Roussel C; Bang B; Clonier F; Lacour JP
    J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):1951-1956. PubMed ID: 27306589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.